SCHEMBL3770052

SCHEMBL3770052

C[CH]C1COCO1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1868381 0.79
SCHEMBL1868379 0.79
SCHEMBL8770051 0.78
SCHEMBL28955 0.78
SCHEMBL7216460 0.76
SCHEMBL1862726 0.72
SCHEMBL394621 0.72
SCHEMBL6641772 0.72
SCHEMBL17741250 0.69
SCHEMBL9729968 0.69

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1999051598-A1 SUBSTITUTED 9H-PYRIDINO[2,3-b]INDOLE AND 9H-PYRIMIDINO[4,5-b]INDOLE DERIVATIVES: SELECTIVE NEUROPEPTIDE y RECEPTOR LIGANDS NEUROGEN CORPORATION (US) 1999-10-14 WO claimed
US-20200203763-A1 HIGH-VOLTAGE STABLE COPOLYMER FOR CONSTITUTING A POLYMER ELECTROLYTE FOR A LITHIUM OR SODIUM CELL ROBERT BOSCH GMBH (DE) 2020-06-25 US disclosed
US-8268825-B2 Method for the treatment of anthrax infections THE BOARD OF REGENTS FOR OKLAHOMA STATE UNIVERSITY (US) 2012-09-18 US disclosed
CN-102112447-A HIV integrase inhibitors from pyridoxine AMBRILIA BIOPHARMA INC 2011-06-29 CN disclosed
US-20100305119-A1 Method for the treatment of anthrax infections NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2010-12-02 US disclosed
US-4657579-A HERBICIDE SANDOZ LTD. (CH) 1987-04-14 US disclosed